Integra Lifesciences Holdings (IART) Tax Provisions (2009 - 2026)

Integra Lifesciences Holdings has disclosed Tax Provisions across 18 years of filings, most recently posting $262000.0 for Q2 2026.

• In Q2 2026, Tax Provisions rose 100.56% year-over-year to $262000.0; the TTM figure through Jun 2026 stood at $7.1 million (up 112.14% YoY), while the FY2025 annual figure was -$47.0 million, down 316.43% from the prior year.
• Tax Provisions came in at $262000.0 for Q2 2026 at Integra Lifesciences Holdings, down from $2.2 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $11.3 million in Q4 2022 to a low of -$46.9 million in Q2 2025.
• Average Tax Provisions over 5 years is -$509944.4, with a median of $1.2 million recorded in 2026.
• Year-over-year, Tax Provisions tumbled 1584.48% in 2025 and surged 146.55% in 2026.
• Over 5 years, Tax Provisions stood at $11.3 million in 2022, then declined by 19.87% to $9.0 million in 2023, then plunged by 65.58% to $3.1 million in 2024, then soared by 93.63% to $6.0 million in 2025, then slumped by 95.64% to $262000.0 in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were $262000.0 in Q2 2026, $2.2 million in Q1 2026, and $6.0 million in Q4 2025.